The conference "From Tumor Biology to Future Clinical Solutions," organized by the MICC, aims to be the premier event for the cancer community in Israel, attracting the world’s leading cancer researchers. This event will bridge the gap between fundamental cancer research and clinical application, addressing the multifaceted nature of cancer.

The geopolitical situation in Israel in the past year has been extremely challenging. However, we continue to believe in the importance of science and our quest for scientific discoveries that could transform patient lives worldwide. Therefore, we have decided to relocate the event to Athens, Greece. To facilitate travel, the Weizmann Institute will provide financial support to a select number of students who submit abstracts.

Please register here: https://conferences.weizmann.ac.il/FTBFC2025/ 

 

 

List of Speakers

Ido Amit

Weizmann Institute of Science. Israel

Alberto Bardelli

University of Torino. Italy

Michal Bassani-Sternberg

Ludwig Institute for Cancer Research, Switzerland

Marcus Conrad

Helmholtz Zentrum München. Germany

Luis Diaz

Memorial Sloan Kettering Cancer Center (MSKCC). USA

Channing Der

UNC School of medicine

 

Julian Downward

The Francis Crick Institute United Kingdom

Omer Dushek

University of Oxford United Kingdom

Moshe Elkabets

Ben Gurion University of the Negev (BGU). Israel

Ayelet Erez

Weizmann Institute of Science. Israel

Neta Erez

Tel Aviv university (TAU). Israel

Gerard Evan

University of Cambridge. United Kingdom

Rong Fan

Yale University. USA

Tamar Geiger

Weizmann Institute of Science (WIS). Israel

Eyal Gottlieb

The University of Texas MD Anderson Cancer Center. USA

Yogesh Goyal

Northwestern University

Kristian Helin

The Institute of Cancer Research (ICR). United Kingdom

Leeat Keren

Weizmann Institute of Science (WIS). Israel

Dan Landau

Cornell University. USA

Michelle Monje

Stanford University. USA

Yaara Oren

Tel Aviv university (TAU). Israel

Timothy P Padera

Harvard-MIT (Massachusetts Institute of Technology). USA

Nick Papandopolous

Johns Hopkins University (JHU). USA

Marina Pasca di Magliano

University of Michigan. USA

Daniel Peeper

The Netherlands Cancer Institute (NKI). The Netherlands

Dana Peer

Memorial Sloan Kettering Cancer Center (MSKCC). USA

Nathan Reticker-Flynn

Stanford University. USA

Zeev Ronai

Cedars Sinai Medical Center, USA

Nitzan Rosenfeld

Queen Mary University of London, United Kingdom

Erik Sahai

The Francis Crick Institute. United Kingdom

Yardena Samuels

Weizmann Institute of Science (WIS). Israel

Ruth Scherz-Shouval

Weizmann Institute of Science Israel

Yuval Shaked

Technion- Israel Institute of Technology. Israel

Efrat Shema

Weizmann Institute of Science Israel

Liran Shlush

Weizmann Institute of Science (WIS). Israel

Marisol Soengas

Centro Nacional de Investigaciones Oncológicas (CNIO). Spain

Jamie Spangler

Johns Hopkins University (JHU). USA

Mario L.Suvà

Harvard University. USA

Victor Velculesco

Johns Hopkins University (JHU). USA